Free Trial

Fresenius SE & Co. KGaA (FSNUY) Stock Forecast & Price Target

$7.98
-0.15 (-1.85%)
(As of 07/15/2024 ET)

Fresenius SE & Co. KGaA - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Based on 3 Wall Street analysts who have issued ratings for Fresenius SE & Co. KGaA in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 3 analysts, 1 has given a hold rating, and 2 have given a buy rating for FSNUY.

Consensus Price Target

N/A

According to the 3 analysts' twelve-month price targets for Fresenius SE & Co. KGaA,

TypeCurrent Forecast
7/17/23 to 7/16/24
1 Month Ago
6/17/23 to 6/16/24
3 Months Ago
4/18/23 to 4/17/24
1 Year Ago
7/17/22 to 7/17/23
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
2 Buy rating(s)
2 Buy rating(s)
2 Buy rating(s)
6 Buy rating(s)
Hold
1 Hold rating(s)
2 Hold rating(s)
2 Hold rating(s)
3 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price TargetN/AN/AN/AN/A
Forecasted UpsideN/AN/AN/AN/A
Get Fresenius SE & Co. KGaA Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for FSNUY and its competitors with MarketBeat's FREE daily newsletter.

FSNUY Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

FSNUY Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Fresenius SE & Co. KGaA Stock vs. The Competition

TypeFresenius SE & Co. KGaAMedical CompaniesS&P 500
Consensus Rating Score
2.67
2.71
2.50
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside1,034.20% Upside7.99% Upside
News Sentiment RatingNeutral News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
9/5/2023HSBC
2 of 5 stars
 DowngradeBuy ➝ Hold
8/9/2023Deutsche Bank Aktiengesellschaft
2 of 5 stars
 UpgradeHold ➝ Buy
8/1/2023Citigroup
3 of 5 stars
 Initiated CoverageBuy
7/12/2023The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageNeutral
1/2/2023Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy
11/28/2022UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Buy
10/27/2022Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight ➝ Overweight€35.00 ➝ €34.00
10/26/2022Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target€30.00 ➝ €24.00
10/26/2022Berenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy€54.95 ➝ €46.10
10/18/2022Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageEqual Weight
7/29/2022DZ Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Sven Kuerten
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold€26.00

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 04:57 PM ET.

FSNUY Forecast - Frequently Asked Questions

Should I buy or sell Fresenius SE & Co. KGaA stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Fresenius SE & Co. KGaA in the last year. There is currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" FSNUY shares.

Do Wall Street analysts like Fresenius SE & Co. KGaA more than its competitors?

Analysts like Fresenius SE & Co. KGaA less than other "medical" companies. The consensus rating score for Fresenius SE & Co. KGaA is 2.67 while the average consensus rating score for "medical" companies is 2.71. Learn more on how FSNUY compares to other companies.


This page (OTCMKTS:FSNUY) was last updated on 7/16/2024 by MarketBeat.com Staff

From Our Partners